Get the Stockscreener App
0.1148
16.57%
-0.0228
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Prophase Labs Inc stock is traded at $0.1148, with a volume of 4.53M.
It is down -16.57% in the last 24 hours and down -57.15% over the past month.
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
See More
Previous Close:
$0.1376
Open:
$0.121
24h Volume:
4.53M
Relative Volume:
1.97
Market Cap:
$5.30M
Revenue:
$7.33M
Net Income/Loss:
$-21.20M
P/E Ratio:
-0.1256
EPS:
-0.9143
Net Cash Flow:
$-12.68M
1W Performance:
-11.69%
1M Performance:
-57.15%
6M Performance:
-66.24%
1Y Performance:
-83.04%
1-Day Range:
$0.1144
$0.128
1-Week Range:
$0.1144
$0.16
52-Week Range:
$0.1144
$0.9349
Prophase Labs Inc Stock (PRPH) Company Profile
Name
Prophase Labs Inc
Sector
Industry
Phone
(215) 345-0919
Address
711 STEWART AVE, SUITE 200, NEW YORK, PA
Compare PRPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.1148 | 6.35M | 7.33M | -21.20M | -12.68M | -0.9143 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-13-21 | Downgrade | Dawson James | Buy → Neutral |
| Jan-20-21 | Initiated | Dawson James | Buy |
Prophase Labs Inc Stock (PRPH) Latest News
ProPhase Labs Delays Q3 Filing Amid Reorganization - MSN
The growth track for ProPhase Labs Inc (PRPH) has changed recently - setenews.com
Is ProPhase Labs Inc. stock a buy in volatile marketsIPO Watch & Technical Entry and Exit Tips - Newser
MSN Money - MSN
Will Fed Rate Hikes Affect Kridhan Infra Limited Stocks OutlookValue Traps to Avoid & Get Free Expert Trading Recommendations - earlytimes.in
ProPhase Labs Inc (PRPH) Q3 2025 Earnings Call Highlights: Strategic Initiatives and Financial ... By GuruFocus - Investing.com Canada
ProPhase Labs Inc (PRPH) Q3 2025 Earnings Call Highlights: Strat - GuruFocus
ProPhase Labs Inc (PRPH) Q3 2025 Earnings Call Highlights: Strategic Initiatives and Financial ... - Yahoo Finance
Prophase Labs Secures Forbearance Agreement with Avtech Capital - MSN
Prophase Labs Faces Unsealed Civil Action Disclosure - MSN
ProPhase Labs stockholders approve digital asset initiatives and stock split authority - Investing.com Australia
Prophase Labs Approves Strategic Proposals at Special Meeting - TipRanks
ProPhase Labs stockholders approve digital asset initiatives and stock split authority By Investing.com - Investing.com South Africa
ProPhase Labs investors approve digital asset powers and stock split plan - Stock Titan
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1 - GlobeNewswire
ProPhase Labs discloses unsealing of False Claims Act lawsuit in New York - Investing.com Nigeria
ProPhase Labs discloses unsealing of False Claims Act lawsuit in New York By Investing.com - Investing.com South Africa
ProPhase Labs updates payment schedule on Avtech equipment lease following Utah judgment - Investing.com Nigeria
ProPhase LabsOn Nov 21, received confirmation from AVTECH agreeing to continue its forbearance under co's existing equipment lease - marketscreener.com
ProPhase Labs updates payment schedule on Avtech equipment lease following Utah judgment By Investing.com - Investing.com South Africa
ProPhase Labs aware that civil action pending in the United States District Court for the Eastern District of New York has been unsealed - marketscreener.com
Prophase Labs- On Nov 21, Received Confirmation From Avtech Agreeing To Continue Its Forbearance Under Co's Existing Equipment Lease - TradingView
[8-K] ProPhase Labs, Inc. Reports Material Event | PRPH SEC FilingForm 8-K - Stock Titan
Stocks of ProPhase Labs Inc (PRPH) are poised to climb above their peers - setenews.com
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2025 Earnings Call Transcript - MSN
ProPhase Labs signals $50M net collection target and strategic initiatives as Crown Medical litigation advances - MSN
Is ProPhase Labs Inc. stock vulnerable to regulatory risksForecast Cut & Advanced Technical Analysis Signals - newser.com
Reversal indicators forming on ProPhase Labs Inc. stock2025 Key Highlights & AI Forecast for Swing Trade Picks - newser.com
ProPhase Labs Reports Q3 Loss Amid Strategic Shifts - TipRanks
Earnings call transcript: ProPhase Labs Q3 2025 posts unexpected EPS loss - Investing.com Nigeria
ProPhase Labs’ Earnings Call: Challenges and Opportunities - The Globe and Mail
What data driven models say about ProPhase Labs Inc.’s future - newser.com
ProPhase Labs Q3 2025 Earnings Call Transcript - MarketBeat
[10-Q] ProPhase Labs, Inc. Quarterly Earnings Report | PRPH SEC FilingForm 10-Q - Stock Titan
ProPhase Labs in talks for strategic initiative, cites undervalued assets By Investing.com - Investing.com Nigeria
ProPhase Labs, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:PRPH) 2025-11-19 - Seeking Alpha
Prophase Labs Unveils Strategic Initiatives and Partnerships - MSN
ProPhase Labs, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2025 - marketscreener.com
ProPhase Labs earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada
ProPhase Labs reported results for the third quarter ended September 30, 2025, and will hold a virtual conference call today at 2pm ET. - marketscreener.com
ProPhase Labs (PRPH) Explores Strategic M&A Opportunities - GuruFocus
ProPhase Labs (PRPH) Q3 Revenue Decline but Future Prospects Bri - GuruFocus
Prophase Labs Inc Stock (PRPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):